It has been shown that transgenic rats overexpressing human OATP4C1 had significantly lower ADMA plasma concentrations and less pronounced hypertension in the setting of renal failure (Toyohara et al. 2009). The gene discussed is SLCO4C1; the disease is hypertensive disorder.